litlas
Log inCreate account

Dara L. Aisner

Active 1997–2026

83
Papers
20,708
Citations
63
h-index
79
i10-index

Citations

Citations per year for Dara L. Aisner1971: 1 citations1990: 1 citations1993: 3 citations1998: 4 citations1999: 24 citations2000: 39 citations2001: 37 citations2002: 59 citations2003: 36 citations2004: 17 citations2005: 23 citations2006: 24 citations2007: 18 citations2008: 10 citations2009: 11 citations2010: 20 citations2011: 15 citations2012: 41 citations2013: 88 citations2014: 103 citations2015: 149 citations2016: 241 citations2017: 228 citations2018: 261 citations2019: 948 citations2020: 1,029 citations2021: 997 citations2022: 779 citations2023: 534 citations2024: 937 citations2025: 378 citations2026: 10 citations1972–1989: no citations, so these years are not shown1991–1992: no citations, so these years are not shown1994–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,370 citing papers, 25.7% of this breakdownChina: 1,591 citing papers, 17.2% of this breakdownItaly: 524 citing papers, 5.7% of this breakdownJapan: 383 citing papers, 4.1% of this breakdownUnited Kingdom: 379 citing papers, 4.1% of this breakdownGermany: 370 citing papers, 4% of this breakdownFrance: 341 citing papers, 3.7% of this breakdownCanada: 307 citing papers, 3.3% of this breakdownSpain: 276 citing papers, 3% of this breakdownSouth Korea: 268 citing papers, 2.9% of this breakdownSwitzerland: 217 citing papers, 2.4% of this breakdownNetherlands: 206 citing papers, 2.2% of this breakdown
0%25.7%Other 21.7%

Institutions

Fields

  • Medicine72.9%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Health Professions1.4%
  • Immunology and Microbiology1%
  • Computer Science0.9%
  • Engineering0.6%
  • Other2.4%

Topics

  • Lung Cancer Treatments and Mutations15.3%
  • Lung Cancer Diagnosis and Treatment7.3%
  • Lung Cancer Research Studies6.8%
  • Cancer Genomics and Diagnostics5.5%
  • Cancer Immunotherapy and Biomarkers4.7%
  • Radiomics and Machine Learning in Medical Imaging2.2%
  • Other58.2%

Coauthors

All papers

Open in search
  1. Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip Pravin Patel, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2022 cited by 1,419

  2. NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

    Authors: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2023 cited by 483

  3. Non–Small Cell Lung Cancer, Version 4.2024

    Authors: Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm M. DeCamp, Aakash Desai, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aditya Juloori, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Jonathan W. Riess, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Lisa Hang - Journal of the National Comprehensive Cancer Network 2024 cited by 756

  4. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    Authors: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Christine M. Lovly, Renato Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2021 cited by 1,006

  5. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Authors: Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric Bernicker, Carol Colasacco, Sanja Đačić, Fred R. Hirsch, Keith M. Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette M. Sholl, Robyn Temple‐Smolkin, Benjamin Solomon, Lesley Souter, Erik Thunnissen, Ming‐Sound Tsao, Christina B. Ventura, Murry W. Wynes, Yasushi Yatabe - Archives of Pathology & Laboratory Medicine 2018 cited by 931

  6. Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

    Authors: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, M.C. Dobelbower, Robert C. Doebele, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Ritsuko Komaki, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Leah J. Leisch, Rogerio Lilenbaum, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2017 cited by 1,325

  7. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

    Authors: David S. Ettinger, Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Scott Gettinger, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Sandip Pravin Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, OCN, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2019 cited by 1,005

  8. The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

    Authors: Tejas Patil, Derek Smith, Paul A. Bunn, Dara L. Aisner, Anh T. Le, Mark J. Hancock, W. Thomas Purcell, Daniel W. Bowles, D. Ross Camidge, Robert C. Doebele - Journal of Thoracic Oncology 2018 cited by 199

  9. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

    Authors: Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric Bernicker, Carol Colasacco, Sanja Đačić, Fred R. Hirsch, Keith M. Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette M. Sholl, Robyn Temple‐Smolkin, Benjamin Solomon, Lesley Souter, Erik Thunnissen, Ming‐Sound Tsao, Christina B. Ventura, Murry W. Wynes, Yasushi Yatabe - Journal of Molecular Diagnostics 2018 cited by 633

  10. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    Authors: Andrew Weickhardt, Benjamin Scheier, Joseph Burke, Gregory N. Gan, Xian Lu, Paul A. Bunn, Dara L. Aisner, Laurie E. Gaspar, Brian D. Kavanagh, Robert C. Doebele, D. Ross Camidge - Journal of Thoracic Oncology 2012 cited by 677

  11. HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

    Authors: Bob T. Li, Dara S. Ross, Dara L. Aisner, Jamie E. Chaft, Meier Hsu, Severine Kako, Mark G. Kris, Marileila Varella‐Garcia, Maria E. Arcila - Journal of Thoracic Oncology 2015 cited by 278

  12. Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

    Authors: Kurtis D. Davies, Anh T. Le, Mariana F. Theodoro, Margaret C. Skokan, Dara L. Aisner, Eamon M. Berge, Luigi Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli, Marco Alloisio, Armando Santoro, D. Ross Camidge, Marileila Varella‐Garcia, Robert C. Doebele - Clinical Cancer Research 2012 cited by 472

  13. Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

    Authors: Lynette M. Sholl, Dara L. Aisner, Marileila Varella‐Garcia, Lynne D. Berry, Dora Dias‐Santagata, Ignacio I. Wistuba, Heidi Chen, Junya Fujimoto, Kelly Kugler, Wilbur A. Franklin, A. John Iafrate, Marc Ladanyi, Mark G. Kris, Bruce E. Johnson, Paul A. Bunn, John D. Minna, David J. Kwiatkowski - Journal of Thoracic Oncology 2015 cited by 430

  14. Resistance Mechanisms to Targeted Therapies in ROS1 + and ALK + Non–small Cell Lung Cancer

    Authors: Caroline E. McCoach, Anh T. Le, Katherine Gowan, Kenneth A. Jones, Laura Schubert, Andrea E. Doak, Adriana Estrada‐Bernal, Kurtis D. Davies, Daniel T. Merrick, Paul A. Bunn, W. Tom Purcell, Rafał Dziadziuszko, Marileila Varella‐Garcia, Dara L. Aisner, D. Ross Camidge, Robert C. Doebele - Clinical Cancer Research 2018 cited by 246

  15. Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience

    Authors: Badi El Osta, Madhusmita Behera, Sungjin Kim, Lynne D. Berry, Gabriel Sica, Rathi N. Pillai, Taofeek K. Owonikoko, Mark G. Kris, Bruce E. Johnson, David J. Kwiatkowski, Lynette M. Sholl, Dara L. Aisner, Paul A. Bunn, Fadlo R. Khuri, Suresh S. Ramalingam - Journal of Thoracic Oncology 2019 cited by 241

  16. DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer

    Authors: Kurtis D. Davies, Aprille Lomboy, Carolyn A. Lawrence, Michael Yourshaw, Gregary T. Bocsi, D. Ross Camidge, Dara L. Aisner - Journal of Thoracic Oncology 2019 cited by 150

  17. RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

    Authors: Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos, Asmin Tulpule, Saurabh Asthana, Collin M. Blakely, Ross A. Okimoto, Luping Lin, Dana S. Neel, Amit J. Sabnis, Jennifer C. Flanagan, Elton Chan, Marileila Varella‐Garcia, Dara L. Aisner, Aria Vaishnavi, Sai‐Hong Ignatius Ou, Eric A. Collisson, Eiki Ichihara, Philip C. Mack, Christine M. Lovly, Niki Karachaliou, Rafael Rosell, Jonathan W. Riess, Robert C. Doebele, Trever G. Bivona - Nature Medicine 2015 cited by 277

  18. MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

    Authors: Robin Guo, Lynne D. Berry, Dara L. Aisner, Jamie Sheren, Theresa A. Boyle, Paul A. Bunn, Bruce E. Johnson, David J. Kwiatkowski, Alexander Drilon, Lynette M. Sholl, Mark G. Kris - Journal of Thoracic Oncology 2019 cited by 174

  19. The Learning Healthcare System: Workshop Summary

    Authors: LeighAnne Olsen, Dara L. Aisner, J. Michael McGinnis - 2013 cited by 587

  20. Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis

    Authors: Sinéad Noonan, Lynne D. Berry, Xian Lu, Dexiang Gao, Anna E. Barón, Patrick Chesnut, Jamie Sheren, Dara L. Aisner, Dan Merrick, Robert C. Doebele, Marileila Varella‐Garcia, D. Ross Camidge - Journal of Thoracic Oncology 2016 cited by 170

  21. Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

    Authors: Collin M. Blakely, Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski, Julia Rotow, Turja Chakrabarti, D. Lucas Kerr, Jacqueline V. Aredo, Bianca Bacaltos, Megan Gee, Lisa Tan, Kirk D. Jones, W. Patrick Devine, Robert C. Doebele, Dara L. Aisner, Tejas Patil, Erin L. Schenk, Trever G. Bivona, Jonathan W. Riess, Melissa H. Coleman, Johannes R. Kratz, David M. Jablons - Journal of Clinical Oncology 2024 cited by 57

  22. PIK3CAMutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

    Authors: Aryana R. Rasti, Amy Guimaraes-Young, Farrah Mikhail Datko, Virginia F. Borges, Dara L. Aisner, Elena Shagisultanova - JCO Precision Oncology 2022 cited by 58

  23. Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer

    Authors: Robert C. Doebele, Amanda Pilling, Dara L. Aisner, Tatiana G. Kutateladze, Anh T. Le, Andrew Weickhardt, Kimi Kondo, Derek J. Linderman, Lynn E. Heasley, Wilbur A. Franklin, Marileila Varella‐Garcia, D. Ross Camidge - Clinical Cancer Research 2012 cited by 1,065

  24. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

    Authors: Aria Vaishnavi, Marzia Capelletti, Anh T. Le, Severine Kako, Mohit Butaney, Dalia Ercan, Sakshi Mahale, Kurtis D. Davies, Dara L. Aisner, Amanda Pilling, Eamon M. Berge, Jhingook Kim, Hidefumi Sasaki, Seung-Il Park, Gregory V. Kryukov, Levi A. Garraway, Peter S. Hammerman, Julia Haas, Steven W. Andrews, Doron Lipson, Philip J. Stephens, Vince A Miller, Marileila Varella‐Garcia, Pasi A. Jänne, Robert C. Doebele - Nature Medicine 2013 cited by 602